Ledger.Open graph →
SEC Form D · filed September 28, 2023

Lila Biologics, Inc

Offering
$10.6M
Sold
$9.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

William Canestaro · Seattle, WADirectorSheila Gujrathi · San Diego, CADirectorJohn Kraft, Ii · Seattle, WAExec · DirectorAnindya Roy · Seattle, WAExec · DirectorWilliam Canestaro · Seattle, WADirectorSheila Gujrathi · La Jolla, CADirectorJohn Kraft, Ii · Seattle, WAExec · DirectorAnindya Roy · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗